Acrivon Therapeutics Inc (ACRV) Stock Price, Quote & News

Company Profile

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 207 8979

Website: acrivon.com

Address:

480 Arsenal Way, Suite 100, Watertown, United States

open_outcry Apr. 24 at 6:37 PM

$ACRV would love to see a run up to the 52-wk high in the coming weeks

1 · Reply

Jstidd Apr. 23 at 9:01 PM

$ACRV Bullish read on today’s 13D/A: RA Capital just bought 3,888,888 shares at $1.80 for about $7.0M in cash, and now beneficially owns 12,284,906 shares, or 28.8% of the company. My takeaway: * a top biotech specialist just added meaningful size * Acrivon brought in fresh cash * yes, there’s dilution, but it was absorbed by a high-conviction institutional buyer That is usually a much better signal than stock being sold into the open market with no strong hand stepping up. good to see a sophisticated holder just leaned in.

2 · Reply

open_outcry Apr. 23 at 8:12 PM

$ACRV held up pretty well today, considering

0 · Reply

blackpoint01 Apr. 23 at 5:50 PM

$ACRV thanks government 😒

0 · Reply

Dylberts Apr. 22 at 7:55 PM

$ACRV has had a nice few days of volume. I still believe in the future here, but now is a great opportunity to take some profits if you're ahead before a new entry point!

2 · Reply

savvy_1 Apr. 22 at 4:22 PM

$ACRV Anyone know when any new data is scheduled to be released? Estimated times anyway?

1 · Reply

Monty3030 Apr. 22 at 2:26 PM

$ACRV Huge volume today!!

0 · Reply

FonsieTrader Apr. 22 at 2:23 PM

$ACRV – Reclaiming key level… continuation in play? 👀 Strong push back above $1.90–$2.00 resistance. TTM Squeeze turning up → momentum shifting. MFI very strong, buyers stepping in aggressively. 💡 DD Angle: • Small cap biotech (~$76M) → reacts fast to volume • Prior spike shows it can move quickly when momentum hits Hold above $2.00 and this can push toward $3.00 👉 Reclaim setups = some of the best runners.

0 · Reply

CyberCuba Apr. 22 at 2:17 PM

$ACRV Highly malignant serous carcinoma of the uterus, ovaries, fallopian tubes (and maybe peritoneum) is the cancer ACRV is targeting and the data so far is pretty good considering nothing else effective now. Certainly ACRV is a nice grab for big pharma if they can make additional progress.

0 · Reply